Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Join SI Premium – FREE
Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rothschild Redburn Downgrades Moderna (MRNA) to Sell
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
